DarioHealth Corp reports results for the quarter ended in September - Earnings Summary

DarioHealth

02/11/2023 13:31

* DarioHealth Corp  DRIO.OQ  reported a quarterly adjusted
loss
of 49 cents​​ per share for the quarter ended in September,
higher than the same quarter last year, when the company
reported EPS of -64 cents.  The mean expectation of
five analysts for the quarter was for a loss of 46 cents per
share. Wall Street expected results to range from -60 cents
to -25 cents per share.
    * Revenue fell 46.7% to $3.52 million from a year ago;
analysts
expected $5.34 million. 
    * DarioHealth Corp's reported EPS for the quarter was a loss
of 49
cents​.
    * The company reported a quarterly loss of $16.9 million.
    * DarioHealth Corp shares had fallen by 69.2% this
quarter and
lost 76.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for DarioHealth
Corp
is $8.00 

This summary was machine generated from LSEG data November 2 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.46          -0.49          Missed
 Jun. 30 2023      -0.52          -0.58          Missed
 Mar. 31 2023      -0.50          -0.45          Beat
 Dec. 31 2022      -0.65          -0.51          Beat